Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Functional Dissection of Metabolic-Sensing Proline Hydroxylation Pathways
PS12-1201 Comprehensive HIV Prevention Project for Health Depts
Serotonin, Impulsivity and Aggressivity in Adolescent Alcohol Use Disorders
Identification of Transforming Genes in Melanoma
The Chemistry of Technetium Related to Nuclear Medicine
Recently added grants:
Association of the Maternal Exome with Risk of an Aneuploid Conception
Genetic Repair of Familial Hypercholesterolemia
Cav-3 in Diabetic Myocardial Injury Following Ischemia/Reperfusion
Genetic variation impacting the airway smooth muscle in children with asthma
Towards Improving Bone Marrow Transplantation via Inhibition of 15-PGDH
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-006
Application #
6828776
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant